NovoCure
-$5.18 (-2.82%) As of 2:47 PM UTC today
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NovoCure and other ETFs, options, and stocks.
About NVCR
NovoCure Ltd. develops treatment for tumors. Its platform is called the Tumor Treating Field which used electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division.
CEO
Asaf Danziger
Employees
1,023
Headquarters
St. Helier, Jersey
Founded
2000
NVCR Key Statistics
Market Cap
20.50B
Price-Earnings Ratio
1.75K
Dividend Yield
—
Average Volume
421.51K
High Today
$183.68
Low Today
$177.23
Open Price
$183.43
Volume
108.04K
52 Week High
$232.76
52 Week Low
$65.99
Analyst Ratings
50%
of 10 ratings
Buy
30%
Hold
50%
Sell
20%
NVCR Earnings
-$0.04
$0.01
$0.07
$0.12
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
$0.01 per share
Actual
Available Jul 29, Pre-Market